Indaptus Therapeutics
(NASDAQ) INDP
Indaptus Therapeutics Financials at a Glance
Market Cap
$3.59M
Revenue (TTM)
$0.00
Net Income (TTM)
$20.85M
EPS (TTM)
$-24.82
P/E Ratio
-0.06
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$1.60
Volume
386
Open
$1.65
Price
$1.60
Volume
386
Open
$1.65
Previous Close
$1.60
Daily Range
$1.58 - $1.65
52-Week Range
$1.52 - $19.91
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$1.60
Volume
386
Open
$1.65
Previous Close
$1.60
Daily Range
$1.58 - $1.65
52-Week Range
$1.52 - $19.91
INDP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Indaptus Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
5
CEO
David Elliot Lazar; Jeffrey A. Meckler
Website
indaptusrx.comHeadquarters
New York City, NY 10019, US
INDP Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-588%
Return on Capital
-6%
Return on Assets
-2%
Earnings Yield
-16.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.59M
Shares Outstanding
2.24M
Volume
386
Short Interest
0.00%
Avg. Volume
58.14K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$19.83M
EBITDA
$19.83M
Operating Cash Flow
$14.82M
Capital Expenditure
$4.00
Free Cash Flow
$14.82M
Cash & ST Invst.
$8.51M
Total Debt
$0.00
Indaptus Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$3.59M
N/A
Market Cap/Employee
$512.53K
N/A
Employees
7
N/A
Net Income
$8.11M
-96.4%
EBITDA
$8.16M
-97.4%
Quarterly Fundamentals
Net Cash
$8.51M
+49.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-2.24%
N/A
Return on Invested Capital
-6.29%
N/A
Free Cash Flow
$3.19M
+6.0%
Operating Cash Flow
$3.19M
+6.0%